CHMP5 and influenza: HAstem-cVLP, an influenza vaccine targeting the conserved stem region of the hemagglutinin trimer, and RBD-cVLP, a SARS-CoV-2 vaccine targeting the receptor-binding domain of the spike protein, were used to evaluate the effect of freeze-drying on the physical and immunological properties of conjugated cVLPs.